What is GE HealthCare Technologies's revenue?

GE HealthCare Technologies (GEHC) generated $21.0B in revenue over the trailing twelve months, up 6.0% year over year.

Is GE HealthCare Technologies profitable?

GE HealthCare Technologies reported $1.9B in net income over the trailing twelve months, a 9.1% net margin.

What are GE HealthCare Technologies's profit margins?

Gross margin is 39.1% and operating margin is 12.6%, with a 9.1% net margin.

What is GE HealthCare Technologies's earnings per share?

GE HealthCare Technologies's diluted EPS over the trailing twelve months is $4.18.

Where does GE HealthCare Technologies's income statement data come from?

Every line is extracted from GE HealthCare Technologies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

GE HealthCare Technologies GEHC Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$20.98B+6.0%	$20.63B+4.8%	$20.25B+3.5%	$19.97B+2.3%	$19.8B+1.6%
Gross profit	$8.21B-1.2%	$8.25B+0.5%	$8.26B+2.2%	$8.3B+3.8%	$8.32B+4.8%
Gross margin	39.1%-2.9pp	40%-1.7pp	40.8%-0.5pp	41.6%+0.6pp	42%+1.3pp
Research and development	$1.26B-5.2%	$1.26B-3.8%	$1.28B0.0%	$1.31B+1.4%	$1.33B+5.7%
Selling, general and administrative	$4.3B+0.7%	$4.23B-1.0%	$4.24B-1.1%	$4.23B-0.5%	$4.27B+0.3%
Compensation and benefits	——	——	——	——	——
Occupancy and equipment	——	——	——	——	——
Depreciation and amortization	——	——	——	——	——
Restructuring charges	——	——	——	——	——
Other operating expenses	$5.56B-0.7%	$5.49B-1.7%	$5.53B-0.9%	$5.54B-0.1%	$5.6B+1.5%
Total operating expenses	$5.56B-0.7%	$5.49B-1.7%	$5.53B-0.9%	$5.54B-0.1%	$5.6B+1.5%
Operating income	$2.65B-2.4%	$2.76B+5.3%	$2.74B+8.9%	$2.76B+12.5%	$2.71B+12.3%
Operating margin	12.6%-1.1pp	13.4%+0.1pp	13.5%+0.7pp	13.8%+1.2pp	13.7%+1.3pp
Interest expense	$449M-14.8%	$440M-12.7%	$492M-12.6%	$490M-13.4%	$527M-5.0%
Interest income	——	——	——	——	——
Other income (expense), net	$94M-42.3%	$157M+180%	$178M+5,833%	$161M+182%	$163M+133%
Income from equity method investments	——	——	——	——	——
Gain (loss) on disposal of assets	——	——	——	——	——
Income before income taxes	$2.58B-6.5%	$2.77B+7.2%	$2.78B+18.0%	$2.8B+19.8%	$2.76B+18.7%
Income tax expense	$605M+18.4%	$615M+15.8%	$492M-21.7%	$481M-32.3%	$511M-27.4%
Net income	$1.91B-12.5%	$2.09B+4.6%	$2.22B+32.4%	$2.24B+41.8%	$2.18B+39.0%
Net margin	9.1%-1.9pp	10.1%0.0pp	11%+2.4pp	11.2%+3.1pp	11%+3.0pp
Net income attributable to noncontrolling interests	——	——	——	——	——
Preferred stock dividends	——	——	——	——	——
Diluted earnings per share	$4.18-12.0%	$4.56+5.3%	$4.84+33.0%	$4.88+41.9%	$4.75+38.9%
Basic earnings per share	$4.18-12.6%	$4.56+4.3%	$4.85+31.8%	$4.90+41.2%	$4.78+38.6%
Weighted-average shares, diluted	1.8B-0.3%	1.8B-0.2%	1.8B-0.1%	1.8B+0.1%	1.8B+0.2%
Weighted-average shares, basic	1.8B-0.1%	1.8B0.0%	1.8B+0.1%	1.8B+0.2%	1.8B+0.3%
Acquisition and disposition-related benefits (charges)	——	——	——	——	——
Share-based compensation expense related to employee stock plans	——	——	——	——	——
Amortization of capitalized software and acquired intangible assets	$296M-2.3%	$291M-7.0%	$294M-8.7%	$297M-11.1%	$303M-12.4%
Amortization Of Intangible Assets, Acquired	——	——	——	——	——
Stock options excluded as their inclusion would be anti-dilutive (in shares)	——	——	——	——	——
Gain resulting from acquisition of joint venture	$0-100%	$97M—	$97M—	$97M—	$97M—
Business Exit Costs1	——	——	——	——	——
Capital investments accrued but not yet paid	$164M-8.9%	$164M+11.6%	$182M+33.8%	$161M+10.3%	$180M+39.5%
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation	——	——	——	——	——
Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months	——	——	——	——	——
Dividends declared (in dollars per share)	——	——	——	——	——
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	——	——	——	——	——
Less: comprehensive income attributable to noncontrolling interest	——	——	——	——	——
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest	——	——	——	——	——
Revenue recognized that was included in deferred income at the beginning of the period	——	——	——	——	——
Net periodic benefit, actuarial valuation and other pension and postretirement plan gains	——	——	——	——	——
Plan asset or obligation reporting threshold	——	——	——	——	——
Defined contribution plan costs	——	——	——	——	——
Depreciation	$299M+12.4%	$287M+7.1%	$278M+5.7%	$269M+3.1%	$266M+4.3%
Effect of exchange rate changes on cash, cash equivalents and restricted cash	——	——	——	——	——
Effective tax rates	——	——	——	——	——
Gain (Loss) on Disposition of Assets	——	——	——	——	——
Gain (Loss) on Sale of Assets and Asset Impairment Charges	——	——	——	——	——
Goodwill Additions	——	——	——	——	——
Translation and other	——	——	——	——	——
Capitalized cloud computing arrangement implementation costs, amortization expense	——	——	——	——	——
EBIT	——	——	——	——	——
Income Taxes Paid, Net	$430M-13.3%	$429M-12.6%	$469M-1.1%	$474M-3.3%	$496M+8.3%
Increase (Decrease) in Accounts and Other Receivables	$156M—	$216M—	$264M—	——	——
Accounts payable	$165M-5.7%	$90M+50.0%	$8M+111%	$44M+128%	$175M+212%
Increase (Decrease) In Contract With Customer, Asset And Deferred Costs	——	——	——	——	——
Increase (decrease) in contract liabilities and current deferred income	$184M+922%	$81M+19.1%	$94M—	$65M—	$18M—
Accrued compensation and employee benefits	$44M+135%	$94M+141%	$107M+463%	$98M+9,700%	-$127M—
Increase (Decrease) in Inventories	——	——	——	——	——
Interest and Debt Expense	$425M-13.6%	$439M-12.9%	$455M-11.5%	$474M-9.2%	$492M-6.8%
Interest Paid, Excluding Capitalized Interest, Operating Activity	$531M-7.3%	$522M-5.1%	$538M-9.0%	$536M-9.8%	$573M-1.7%
Net interest and investment income (loss)	——	——	——	——	——
Changes in noncontrolling interests	——	——	——	——	——
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	——	——	——	$712M—	-$706M—
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$3.14B-177%	-$1.05B-14.6%	-$1.02B-33.6%	-$1.01B-35.2%	-$1.13B-136%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	——	——	——	——	——
Net Income Loss Attributable To Noncontrolling Interest	——	——	——	——	——
Net Income Loss Attributable To Redeemable Noncontrolling Interest	——	——	——	——	——
Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component	-$265M+29.7%	-$288M+28.9%	-$322M+9.3%	-$349M-0.6%	-$377M-2.2%
Noncontrolling Interest, Decrease From Redemptions And Distributions To Noncontrolling Interest Holders And Other	——	——	——	——	——
Number of operating segments	——	——	——	——	——
Number of reportable segments	——	——	——	——	——
AOCI before reclass, net of taxes	——	——	——	——	——
Cash flow hedges	——	——	——	——	——
Unrealized gains (losses) on hedge instruments	——	——	——	——	——
Foreign currency translation gains (losses)	——	——	——	——	——
Net investment hedges	——	——	——	——	——
Other comprehensive income (loss)	——	——	——	——	——
Other comprehensive income/(loss)	——	——	——	——	——
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax	——	——	——	——	——
Other items, net	——	——	——	——	——
Other income, net (Note 6)	$94M-42.3%	$157M+180%	$178M+5,833%	$161M+182%	$163M+133%
All other operating activities	——	——	——	——	——
Payment for (Proceeds from) Other Investing Activity	——	——	——	$205M+720%	$102M+1,940%
Payments for Repurchase of Common Stock	$300M—	$200M—	$200M—	$100M—	——
Payments For Restructuring And Other Adjustments	——	——	——	——	——
Payments of Dividends	$64M+12.3%	$64M+16.4%	$62M+14.8%	$59M+7.3%	$57M+3.6%
Payment, Tax Withholding, Share-Based Payment Arrangement	$33M-70.0%	$42M-54.8%	$44M-52.2%	$78M—	$110M—
Payments to Acquire Businesses, Net of Cash Acquired	$2.41B+313%	$378M+20.8%	$333M—	$333M—	$582M—
Payments to Acquire Investments	$111M+171%	$118M+195%	$89M+48.3%	$38M—	$41M—
Payments to Acquire Productive Assets	$508M+24.5%	$482M+20.2%	$450M+14.5%	$430M+12.3%	$408M+4.9%
Pension and Other Postretirement Benefits Expense, Employer Contribution, Cost	——	——	——	——	——
Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash	-$244M+27.6%	-$267M+25.2%	-$294M+5.8%	-$315M-3.3%	-$337M-5.0%
Proceeds from debt with original maturities of more than three months	$3.89B+291%	$2.73B+175%	$1.5B—	$2.49B—	$994M—
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options	$27M-27.0%	$37M+12.1%	$27M-20.6%	$30M—	$37M—
Financing — other	-$77M-63.8%	-$81M-138%	-$62M-17.0%	-$45M+23.7%	-$47M0.0%
Short-term borrowings/(repayments) less than 90 days — net	——	——	——	——	$0—
Standard and Extended Product Warranty Accrual, Decrease for Payments	——	——	——	——	——
Reclassified net gains (losses) from AOCI into earnings	——	——	——	——	——
Repayments of Debt, Maturing in More than Three Months	$2.51B+65.1%	$1.77B+24.6%	$1.52B+50.9%	$1.52B+51.5%	$1.52B+51.9%
Restructuring Costs And Asset Impairment Charges	——	——	——	——	——
Revenue From Contract With Customer Excluding Assessed Tax	$20.98B+6.0%	$20.63B+4.8%	$20.25B+3.5%	$19.97B+2.3%	$19.8B+1.6%
Stock-based compensation	$143M+26.5%	$130M+4.0%	$127M+1.6%	$111M-15.9%	$113M-8.9%
Spin-Off And Separation Costs	——	——	——	——	——
Foreign currency exchange and other	——	——	——	——	——
Current-period accruals	——	——	——	——	——
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture	——	——	——	——	——
Number of shares purchased (in shares)	——	——	——	——	——
Treasury stock, value, acquired	——	——	——	——	——
Add: dilutive effect of potential common shares (in shares)	——	——	——	——	——
EBITDA	$3.24B-1.2%	$3.34B+4.2%	$3.31B+6.8%	$3.33B+9.1%	$3.28B+8.8%
EBITDA margin	15.5%-1.1pp	16.2%-0.1pp	16.3%+0.5pp	16.7%+1.0pp	16.6%+1.1pp
EBIT	$2.65B-2.4%	$2.76B+5.3%	$2.74B+8.9%	$2.76B+12.5%	$2.71B+12.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about GE HealthCare Technologies.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is GE HealthCare Technologies's revenue?: GE HealthCare Technologies (GEHC) generated $21.0B in revenue over the trailing twelve months, up 6.0% year over year.
Is GE HealthCare Technologies profitable?: GE HealthCare Technologies reported $1.9B in net income over the trailing twelve months, a 9.1% net margin.
What are GE HealthCare Technologies's profit margins?: Gross margin is 39.1% and operating margin is 12.6%, with a 9.1% net margin.
What is GE HealthCare Technologies's earnings per share?: GE HealthCare Technologies's diluted EPS over the trailing twelve months is $4.18.
Where does GE HealthCare Technologies's income statement data come from?: Every line is extracted from GE HealthCare Technologies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.